Novartis Ireland Limited

Lobbying Organisation Novartis Ireland Limited

Date published 21 Jan, 2026

Relevant Matter Public policy or programme

Public Policy Area Health

Period 1 Sep, 2025 to 31 Dec, 2025

Specific Details Invited to the Joint Oireachtas All Party Committee on Orphan Drugs (3/12/25)

Intended results Implementation of Life Sciences commitments in programme for government for Rare Diseases Fast and Fair Access to Innovation and Genetic Screening

Name of person primarily responsible for lobbying on this activity Eibhlin Mulroe

Did any Designated Public Official(DPO) or former Designated Public Official(DPO) carry out lobbying activities on your behalf in relation to this return? You must include yourself, and answer Yes, if you are a current DPO or a DPO at any time in the past. (What is a Designated Public Official?) No

Did you manage or direct a grassroots campaign? No

Was this lobbying done on behalf of a client? No

Lobbying activity

The following activities occurred for this specific Subject Matter Area.

Event / Reception (1)

Made a comment at the meeting that to be competitive, government need to adopt and implement a Life Science Strategy for Ireland, fast and fair access to innovative treatments and the importance of genetic screening.

Informal communication (1)

Brief informal discussion about improving the timelines regarding access to innovation with Deputy O'Sullivan.

Designated public officials lobbied

The following DPOs were lobbied during this return period on this specific Subject Matter Area. These DPOs were involved in at least one of the Lobbying Activities listed above, but not necessarily all of them. As returns are specific to a Subject Matter Area the above Lobbying Activities may be associated with multiple returns.

Colm Burke TD (Dáil Éireann, the Oireachtas)

Pádraig O'Sullivan TD (Dáil Éireann, the Oireachtas)

Shane Moynihan TD (Dáil Éireann, the Oireachtas)

John Lahart TD (Dáil Éireann, the Oireachtas)